1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Product and Services 5.2.5 Competitive Rivalry Within the Industry 6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 6.1 Market Drivers 6.1.1 Rise in Number of Smokers 6.1.2 High Prevalence of COPD 6.1.3 Urbanization and Growing Pollution Levels 6.1.4 Increase In the Demand For Respiratory Devices in Private Hospitals and Clinics 6.1.5 Development of Advanced Technologies 6.2 Market Restraints 6.2.1 Reimbursement Concerns 6.2.2 High Costs Associated With the Medication 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Type of Device 7.1.1 Spirometers 7.1.2 Peak Flow Meters 7.1.3 Sleep Test Devices 7.1.4 Gas Analyzers 7.1.5 Pulse Oximeters 7.1.6 Capnographs 7.2 By Geography 7.2.1 Europe 7.2.1.1 France 7.2.1.2 Germany 7.2.1.3 United Kingdom 7.2.1.4 Italy 7.2.1.5 Spain 7.2.1.6 Rest of Europe 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Calondo Pharmaceuticals Inc. 9.2 Covidien plc 9.3 Draegerwerk AG 9.4 GE Healthcare 9.5 Maquet 9.6 Merck & Co. Inc 9.7 Philips Healthcare 9.8 Resmed 9.9 Siemens Healthcare 9.10 List Not Exhaustive 10. Future of the Market

GE Healthcare, Philips Healthcare, Siemens Healthcare, Resmed, Merck & Co. Inc., Calondo Pharmaceuticals Inc., Covidien, Draegerwerk, Maquet